US Pharmaceutical Corporation
US Pharmaceutical Corporation has 16 on-market SKUs in the DSLD, first entered 2013-10-25. 25.0% of its products declare at least one proprietary blend, and 0.0% of all its all-time SKUs are now off-market.
16
on-market SKUs
25.0%
with a blend
0.0%
gummies
0.0%
off-market churn
Report card
- Median dose adequacy (elemental dose ÷ studied low dose, pooled across compounds): 0.096
- % with a third-party certification statement (USP/NSF/Informed Sport/GMP, as asserted on label): 62.5%
- Average excipient count per product: 7.6
- First entry: 2013-10-25 · Latest entry: 2023-11-22
- Mineral/vitamin rows by quality tier: tier 1: 55.9%, tier 2: 11.8%, tier 3: 5.1%, unrated: 27.2%
Products (16)
| Product | Form | Status |
|---|---|---|
| Concept DHA | Capsule | on-market |
| Concept OB | Capsule | on-market |
| Concept-OB | Capsule | on-market |
| Fushion | Capsule | on-market |
| Fusion Plus | Capsule | on-market |
| Hemocyte F | Tablet or Pill | on-market |
| Hemocyte Plus Capsules | Capsule | on-market |
| Integra | Capsule | on-market |
| Integra Plus | Capsule | on-market |
| Provida OB | Capsule | on-market |
| Provida OB | Capsule | on-market |
| Restora | Capsule | on-market |
| Restora | Capsule | on-market |
| Restora RX | Capsule | on-market |
| Restora Rx | Capsule | on-market |
| Tandem Plus | Capsule | on-market |